I am a physician-scientist who studies and treats infectious diseases. The goal of my laboratory is to discover and exploit molecular vulnerabilities in bacteria in order to design faster, cheaper, less toxic and more effective therapeutics to treat life-threatening infections.

Nooshin Navidi Latour heads communications for the Vice Chancellor Office for Science Policy and Strategy, UCSF Bakar Institute for Computational Health Sciences Institute (BCHSI) and UCSF Precision Medicine. She was formerly in charge of communications and marketing at the UCSF Clinical and Translational Science Institute (CTSI) for several years. Previously, Latour was at the Lucile Packard Foundation for Children's Health, Bay Area Video Coalition, think tank Next 10, The Japan Times, and a couple of early-stage startups.

Dr. Krogan was born and raised in Regina, Saskatchewan, Canada, obtained his undergraduate degree from the University of Regina and his PhD from the University of Toronto. Dr. Krogan’s lab at UCSF focuses on developing and applying quantitative, systematic proteomic and genetic approaches to study complex biological and biomedical problems. At present time, the Krogan group is focused on studying cancer, infectious disease and psychiatric disorders.

In the Bondy-Denomy lab, we study CRISPR-Cas bacterial immune systems in an effort to understand their role in antagonizing viruses called bacteriophages. We are very interested in how CRISPR works and the ways that phages inhibit and evade CRISPR-Cas function.

Dr. Gretchen Kiser is the Executive Director of the Research Development Office (RDO) at the University of California San Francisco.